| Term 
 
        | Penicillin Mechanism of Action |  | Definition 
 
        | Bactericidal; Weakens cell wall causing cell wall to burst |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Narrow spectrum penicillinase sensitive; Narrow spectrum penicillinase resistant; Broad spectrum; Extended spectrum |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bacterial infections- specific to infection |  | 
        |  | 
        
        | Term 
 
        | Penicillin Contraindications |  | Definition 
 
        | Hypersensitivity; Caution in renal disease (toxicity); pregnancy; lactation |  | 
        |  | 
        
        | Term 
 
        | Penicillin Serious Adverse Effects |  | Definition 
 
        | Neurotoxicity if blood levels are too high |  | 
        |  | 
        
        | Term 
 
        | Penicillin Common Adverse Effects |  | Definition 
 
        | Nausea, Vomiting, Diarrhea; Pain at injection site |  | 
        |  | 
        
        | Term 
 
        | Penicillin Preadministration assessment |  | Definition 
 
        | Cultures; Renal function; From a nursing perspective- know that different forms of penicillin have different admin routes (Pen VK is only oral form) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Observe patient for at least 30 min after giving parenteral dose- S/S allergic reaction; Renal function (Creatinine and BUN) |  | 
        |  | 
        
        | Term 
 
        | Penicillin Key Patient Education |  | Definition 
 
        | Pen VK oral can be taken with meals; Complete the prescribed course of treatment; Report signs of allergic reaction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta-lactamase, specifically penicillinase, renders Penicillin inactive; Avoid combining with bacteriostatic antibiotics b/c won't work; probenecid prolongs effects |  | 
        |  | 
        
        | Term 
 
        | Cephalosporins 'Cefazolin' Mechanism of Action |  | Definition 
 
        | Bactericidal; Weakens cell wall |  | 
        |  | 
        
        | Term 
 
        | Cephalosporins 'Cefazolin' Indications |  | Definition 
 
        | Bacteria- specific to suceptibility |  | 
        |  | 
        
        | Term 
 
        | Cephalosporins 'Cefazolin' Contraindications |  | Definition 
 
        | Hypersensitivity to cephalosporins or severe allergic reactions to penicillin (cross-reactivity) |  | 
        |  | 
        
        | Term 
 
        | Cephalosporins 'Cefazolin' Serious Adverse Effects |  | Definition 
 
        | Allergic Reaction; Bleeding (cefotan only) |  | 
        |  | 
        
        | Term 
 
        | Cephalosporins 'Cefazolin' Common Adverse Effects |  | Definition 
 
        | Thrombophlebitis at IV infusion site; Pain at IM injection site; Disulfiram-like reaction (get nausea/sick) when taking cefotetan and alcohol |  | 
        |  | 
        
        | Term 
 
        | Cephalosporins 'Cefazolin' Preadministration assessment |  | Definition 
 
        | Renal function (dosage should be reduced for renal insufficiency- except ceftriaxone) |  | 
        |  | 
        
        | Term 
 
        | Cephalosporins 'Cefazolin' Notes |  | Definition 
 
        | 4 generations- as they progress there is more activity against gram-negative bacteria and anaerobes, increasing resistance to beta-lactamase, increased ability to reach cerebral spinal fluid |  | 
        |  | 
        
        | Term 
 
        | Vancomycin Mechanism of Action |  | Definition 
 
        | Inhibits cell wall synthesis leading to cell death |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | C. difficile (pseudomembranous colitis); MRSA; Serious infections that are susceptible or in patients with Penicillin allergy |  | 
        |  | 
        
        | Term 
 
        | Vancomycin Contraindications |  | Definition 
 
        | Hypersensitivity; Possible patients with known corn or corn product allergies; Pregnancy |  | 
        |  | 
        
        | Term 
 
        | Vancomycin Serious Adverse Effects |  | Definition 
 
        | Ototoxicity (often reversible); Immune-mediated thrombocytopenia |  | 
        |  | 
        
        | Term 
 
        | Vancomycin Common Adverse Effects |  | Definition 
 
        | Rapid IV infusion- flushing, rash, pruritis, urticartia, tachycardia, and hypotension (uncomfortable for patient); Thrombophlebitis |  | 
        |  | 
        
        | Term 
 
        | Vancomycin Preadministration assessment |  | Definition 
 
        | Cultures; WBC; Fever; Renal function |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Periodic CBC if taking for long time or high doses; Serum concentrations: trough 10-20 mg/L |  | 
        |  | 
        
        | Term 
 
        | Vancomycin Key Patient Education |  | Definition 
 
        | Report S/S of allergy; Report decreased hearing |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Use with gentamicin increases risk for nephrotoxicity |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides 'Gentamicin' Mechanism of Action |  | Definition 
 
        | Bactericidal; Disrupts bacterial protein synthesis |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides 'Gentamicin' Indications |  | Definition 
 
        | Aerobic gram negative bacilli; Cannot kill anaerobes |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides 'Gentamicin' Contraindications |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides 'Gentamicin' Serious Adverse Effects |  | Definition 
 
        | Ototoxicity (impairs both hearing and balance)- associated with elevated trough levels; Nephrotoxicity associated with total cumulative dose and high peak levels; Neuromuscular blockade; Blood dyscrasias |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides 'Gentamicin' Common Adverse Effects |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides 'Gentamicin' Preadministration assessment |  | Definition 
 
        | Caution in patients with renal impairment, pre-existing hearing impairment, myasthenia gravis, patients receiving other ototoxic or nephrotoxic drugs and neuromuscular blocking agents |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides 'Gentamicin' Monitoring |  | Definition 
 
        | Serum levels: Trough only if dosing one time per day; Peak and trough if divided doses; Trough: drawn just before dose given, Peak: drawn 30 minutes after IV infusion complete; Renal function: BUN and creatinine |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides 'Gentamicin' Key Patient Education |  | Definition 
 
        | Report symptoms of ototoxicity (tinnitus, hearing loss, persistent headache, nausea, unsteadiness, dizziness, vertigo) |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides 'Gentamicin' Notes |  | Definition 
 
        | Not absorbed by GI tract Does not enter CSF
 Rapidly excreted by kidneys
 Risk for toxicity increases with concomitant neurotoxic, ototoxic,  or nephrotoxic drugs; extremes in age, dehydration
 |  | 
        |  | 
        
        | Term 
 
        | Quinolone 'Ciprofloxacin' Mechanism of Action |  | Definition 
 
        | Bactericidal; Inhibits bacterial enzymes |  | 
        |  | 
        
        | Term 
 
        | Quinolone 'Ciprofloxacin' Indications |  | Definition 
 
        | Preferred drug for preventing Anthrax in people who have inhaled spores; Active against a variety of organisms; Not useful for anaerobes |  | 
        |  | 
        
        | Term 
 
        | Quinolone 'Ciprofloxacin' Contraindications |  | Definition 
 
        | Hypersensitivity; Tizanidine (antifungal) administration- risk of toxicity |  | 
        |  | 
        
        | Term 
 
        | Quinolone 'Ciprofloxacin' Serious Adverse Effects |  | Definition 
 
        | Achilles tendon rupture (particularly elderly and children) |  | 
        |  | 
        
        | Term 
 
        | Quinolone 'Ciprofloxacin' Common Adverse Effects |  | Definition 
 
        | GI reactions; Dizziness; Headache; Restlessness; Confusion; Candida infections; Elderly: confusion, somnolence, psychosis, visual disturbances; Phototoxicity |  | 
        |  | 
        
        | Term 
 
        | Quinolone 'Ciprofloxacin' Preadministration assessment |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Quinolone 'Ciprofloxacin' Monitoring |  | Definition 
 
        | Renal function CBC; PT/INR if patient on warfarin |  | 
        |  | 
        
        | Term 
 
        | Quinolone 'Ciprofloxacin' Key Patient Education |  | Definition 
 
        | Aluminum or Magnesium containing antacids, iron, zinc, sucralfate, milk and dairy products should be taken 6 hours prior or 2 hours after administration; Avoid sun exposure- sunscreen not effective |  | 
        |  | 
        
        | Term 
 
        | Quinolone 'Ciprofloxacin' Notes Absorption can be reduced by compounds that contain cations |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sulfonamide 'Sulfamethoxazole-trimethoprim' Mechanism of Action |  | Definition 
 
        | Bacteriostatic; Inhibits synthesis of folic acid in bacterial cells |  | 
        |  | 
        
        | Term 
 
        | Sulfonamide 'Sulfamethoxazole-trimethoprim' Indications |  | Definition 
 
        | UTI (e. coli) Susceptible Bacteria; Pneumocystis Pneumonia (PCP) |  | 
        |  | 
        
        | Term 
 
        | Sulfonamide 'Sulfamethoxazole-trimethoprim' Contraindications |  | Definition 
 
        | Hypersensitivity; Infants <2 months; Pregnant patients at therm; Lactation; Megaloblastic anemia due to folate deficiency |  | 
        |  | 
        
        | Term 
 
        | Sulfonamide 'Sulfamethoxazole-trimethoprim' Serious Adverse Effects |  | Definition 
 
        | Hypersensitivity; Blood dyscrasias; Hemolytic anemia in susceptible patients; Kernicterus (neurologic damage due to elevated bilirubin) in newborns; Stevens-Johnson syndrome (rare) |  | 
        |  | 
        
        | Term 
 
        | Sulfonamide 'Sulfamethoxazole-trimethoprim' Common Adverse Effects |  | Definition 
 
        | Rash; Urticaria; Anorexia; Nausea; Vomiting; Photosensitivity |  | 
        |  | 
        
        | Term 
 
        | Sulfonamide 'Sulfamethoxazole-trimethoprim' Preadministration assessment |  | Definition 
 
        | Renal function (primarily excreted via kidneys) |  | 
        |  | 
        
        | Term 
 
        | Sulfonamide 'Sulfamethoxazole-trimethoprim' Monitoring |  | Definition 
 
        | Periodic CBC in long term therapy |  | 
        |  | 
        
        | Term 
 
        | Sulfonamide 'Sulfamethoxazole-trimethoprim' Key Patient Education |  | Definition 
 
        | Maintain adequate hydration (8-10 glasses of fluid per day)- older sulfas form crystals in the kidneys; Report sore throat, fever, pallor; Take on empty stomach; Minimize sun exposure |  | 
        |  | 
        
        | Term 
 
        | Sulfonamide 'Sulfamethoxazole-trimethoprim' Notes |  | Definition 
 
        | Cross-allergy; Thiazide diuretics, loop diuretics, sulfonylurea |  | 
        |  | 
        
        | Term 
 
        | Macrolide 'Erythromycin' Mechanism of action |  | Definition 
 
        | Inhibition of protein synthesis- bacteriostatic; Preferred treatment for Legionaires' Disease |  | 
        |  | 
        
        | Term 
 
        | Macrolide 'Erythromycin' Indications |  | Definition 
 
        | Similar to penicillin; works agains Gram-negative and Gram-positive bacteria |  | 
        |  | 
        
        | Term 
 
        | Macrolide 'Erythromycin' Contraindications |  | Definition 
 
        | Hypersensitivity; Congenital QT prolongation; Certain antidysrhythmic drugs |  | 
        |  | 
        
        | Term 
 
        | Macrolide 'Erythromycin' Serious Adverse Effects |  | Definition 
 
        | QT prolongation and sudden death (high concentrations) when combined with CYP3A4 inhibitor; Bowel suprainfection |  | 
        |  | 
        
        | Term 
 
        | Macrolide 'Erythromycin' Common Adverse Effects |  | Definition 
 
        | GI disturbance (minimize by administering with food); Thrombophlebitis; Hypertrophic pyloric stenosis in infants |  | 
        |  | 
        
        | Term 
 
        | Macrolide 'Erythromycin' Preadministration assessment |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Macrolide 'Erythromycin' Monitoring |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Macrolide 'Erythromycin' Key Patient Education |  | Definition 
 
        | Taking on empty stomach is preferred but can take with food if GI upset; Notify prescriber of severe/persistent diarrhea |  | 
        |  | 
        
        | Term 
 
        | Macrolide 'Erythromycin' notes |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tetracyclines Mechanism of Action |  | Definition 
 
        | Bacteriostatic; Inhibits protein synthesis; Broad spectrum antibiotic |  | 
        |  | 
        
        | Term 
 
        | Tetracyclines Indications |  | Definition 
 
        | First line for rickettsial diseases, Chlamydia, brucellosis, cholera, Lyme disease, anthrax, H. pylori |  | 
        |  | 
        
        | Term 
 
        | Tetracyclines Contraindications |  | Definition 
 
        | Hypersensitivity; Last half of pregnancy, infancy, childhood up to 8 years of age; Renal insufficiency |  | 
        |  | 
        
        | Term 
 
        | Tetracyclines Serious Adverse Effects |  | Definition 
 
        | Hepatotoxicity (high dose IV administration); Renal toxicity (when renal impairment already exists) |  | 
        |  | 
        
        | Term 
 
        | Tetracyclines Common Adverse Effects |  | Definition 
 
        | GI irritation; Suprainfection causing severe diarrhea or overgrowth of fungi- itching, inflammatory lesions, black furry tongue; Photosensitivity |  | 
        |  | 
        
        | Term 
 
        | Tetracyclines Preadministration assessment |  | Definition 
 
        | Renal function (mostly renal excretion); Pregnancy |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tetracyclines Key Patient Education |  | Definition 
 
        | Notify prescriber if diarrhea or symptoms of fungal infection; Do not take with drugs of food products containing metal ions separate by at least 2 hours; Use sunscreen |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | May cause permanent discoloration of teeth when used during tooth development; Can form non absorbable chelates with metal ions such as calcium, iron, magnesium, aluminum, zinc)- all interfere with tetracycline absorption, separate by at least 2 hours |  | 
        |  | 
        
        | Term 
 
        | Purine Nucleoside Analogue 'Acyclovir' Mechanism of Action |  | Definition 
 
        | Inhibits viral Replication |  | 
        |  | 
        
        | Term 
 
        | Purine Nucleoside Analogue 'Acyclovir' Indications |  | Definition 
 
        | Herpes simplex, Varicella-zoster |  | 
        |  | 
        
        | Term 
 
        | Purine Nucleoside Analogue 'Acyclovir' Contraindications |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Purine Nucleoside Analogue 'Acyclovir' Serious Adverse Effects |  | Definition 
 
        | Thrombotic Thrombocytopenia Purpura; Stevens Johnson Syndrome; Renal failure |  | 
        |  | 
        
        | Term 
 
        | Purine Nucleoside Analogue 'Acyclovir' Common Adverse Effects |  | Definition 
 
        | Contact dermatitis (topical application); GI disturbance; Headache; Malaise Elderly: neurologic adverse effects
 |  | 
        |  | 
        
        | Term 
 
        | Purine Nucleoside Analogue 'Acyclovir' Preadministration assessment/Monitoring |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Purine Nucleoside Analogue 'Acyclovir' Key Patient Education |  | Definition 
 
        | Maintain adequate hydration (oral tx); If intermittent therapy- initiate therapy at earliest sign or symptom of breakout; Use gloves to apply ointment(prevent transmission); Cannot be given IM |  | 
        |  |